From Titan Company, Power Grid to Bharti Hexacom, Cipla – Here are 8 stocks to watch

view original post

A mix of earnings surprises, acquisitions, and fundraising announcements have pushed several companies into the spotlight. Here is a closer look at what is driving these stocks today.

Market recap

Indian markets ended on a flat note after a volatile session on November 3. The Sensex closed 39.78 points higher at 83,978.49, while the Nifty inched up 41.25 points to end at 25,763.35

Stocks to watch today, November 4

Titan Company

Titan Company reported a 43% jump in net profit to Rs 1,006 crore for the September quarter of FY26, compared to Rs 705 crore a year ago. The rise in profit was mainly due to higher gold prices and steady festive demand. The company’s revenue also increased 25% to Rs 16,534 crore from Rs 13,215 crore in the same period last year.

Power Grid

Power Grid Corporation posted a 6% year-on-year (YoY) fall in profit to Rs 3,566 crore, while revenue inched up 1.8% to Rs 11,476 crore. The company’s EBITDA fell 6.1% to Rs 9,114 crore, leading to narrower margins of 79.4% versus 86% last year.

Bharti Hexacom

Bharti Hexacom, a subsidiary of Bharti Airtel, reported a 66.4% YoY jump in net profit to Rs 421 crore, led by higher data usage and smartphone additions. Revenue grew 10.5% YoY to Rs 2,317 crore, supported by improving average revenue per user (ARPU) and a strong showing across business segments.

Cipla

Cipla announced a deal to acquire 100% of Inzpera Healthsciences Ltd for about Rs 110.65 crore. Once the transaction is complete, Inzpera will become a wholly owned subsidiary of Cipla. The acquisition aligns with Cipla’s broader focus on strengthening its consumer healthcare portfolio.

Zydus Lifesciences

Zydus Lifesciences said its board will meet on November 6 to consider raising up to Rs 5,000 crore through methods such as QIP, rights issue, or private placement. The proposal will require shareholder approval via postal ballot, marking a potential capital infusion move for the company’s expansion and strategic needs.

Gland Pharma

Pharma manufacturer Gland Pharma recorded a 12.3% YoY rise in profit to Rs 184 crore for Q2 FY26. Revenue increased 5.8% YoY to Rs 1,486.8 crore, driven by steady demand for injectables. EBITDA grew 5.8% to Rs 314 crore, while margins remained stable at 21.1%, indicating controlled expenses amid moderate growth.

Godfrey Phillips

Cigarette manufacturer Godfrey Phillips India posted a 22.9% YoY increase in profit to Rs 305 crore, even though revenue was nearly flat at Rs 1,632 crore. EBITDA grew 13.4% YoY to Rs 314.5 crore, while margins improved to 19.3% from 17%, reflecting better operational control and cost management.

Indus Towers

Indus Towers reported a steady second-quarter performance with revenue rising 9.7% year-on-year to Rs 8,190 crore. Adjusted EBITDA also increased 14.9% from a year earlier.

VRL Logistics

VRL Logistics reported a 39% YoY jump in net profit to Rs 50 crore for the September quarter, up from Rs 36 crore a year ago. However, the company’s revenue from operations remained nearly unchanged at Rs 796.5 crore. On the operating front, EBITDA rose 14.2% YoY to Rs 151.4 crore, reflecting cost efficiency despite limited topline growth.

Key earning to watch today

State Bank of India, Adani Enterprises, Adani Ports, Mahindra & Mahindra, and IndiGo will be in focus today as investors track their quarterly results and key business updates.